))
Ep. 81 - Data-Driven Growth: Immunocore CEO Bahija Jallal on Expanding TCR Therapies
Manage episode 475108016 series 3571902
On the latest episode of The BioCentury Show, Editor in Chief Simone Fishburn speaks with Bahija Jallal, CEO of Immunocore and the former president of Medimmune. While some biotechs are circumspect about gathering data during clinical trials that might not support the product in question, Jallal sees it as part of the obligation to patients and the field to learn as much as possible, as efficiently as possible. And that strategy has informed how the company will take its TCR technology into earlier lines of treatment and new indications.
View full story: https://www.biocentury.com/article/655504
#biopharma #pharma #biotech #lifescience #RandD #DrugDevelopment #CEO
00:00 - Introduction
04:18 - Getting a New Modality to Market
17:15 - Infectious Pipeline
22:04 - Autoimmune Pipeline
27:24 - Leading in Challenging Times
Chapters
1. Introduction (00:00:00)
2. Getting a New Modality to Market (00:04:18)
3. Infectious Pipeline (00:17:15)
4. Autoimmune Pipeline (00:22:04)
5. Leading in Challenging Times (00:27:24)
33 episodes
Share
